Our CEO

American citizen;
Doctor of Biochemistry;
Master of Business Administration (MBA);
U.S. Registered Patent Agent;
Possesses extensive experience in pharmaceutical R&D and international GMP compliance and management.
Dr. Li has conducted cancer research at the Department of Pharmacology, Yale School of Medicine, and served as a biologist at the National Institutes of Health (NIH).
He previously worked as a Review Scientist at the U.S. Food and Drug Administration (FDA).
He also served as Deputy Director of Regulatory Affairs and Senior Scientist at Wyeth (subsequently acquired by Pfizer Inc.).